Gene therapy for hemophilia: are viral vectors really feasible?
- 1 February 2003
- journal article
- Published by Wiley in Journal of Thrombosis and Haemostasis
- Vol. 1 (2) , 218-219
- https://doi.org/10.1046/j.1538-7836.2003.00095.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Sustained and Complete Phenotype Correction of Hemophilia B Mice Following Intramuscular Injection of AAV1 Serotype VectorsMolecular Therapy, 2001
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsGene Therapy, 2001
- Sustained expression of human factor VIII in mice using a parvovirus-based vectorBlood, 2000
- Efficient lentiviral transduction of liver requires cell cycling in vivoNature Genetics, 2000
- AAV vectors: is clinical success on the horizon?Gene Therapy, 2000
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Spliceosome-mediated RNA trans-splicing as a tool for gene therapyNature Biotechnology, 1999
- Human gene targeting by viral vectorsNature Genetics, 1998